Skip to main content
. 2012 Sep;86(18):9666–9674. doi: 10.1128/JVI.00958-12

Fig 1.

Fig 1

Receptor binding specificity of SC/09 and HA/226R. (A) Hemagglutination assay of two viruses with 0.5% cRBCs treated as follows: cRBCs, untreated; α-2,3 cRBC, Vibrio cholerae neuraminidase (VCNA) treated and resialylated with α-2,3 glycans; α-2,6 cRBC, VCNA treated and resialylated with α-2,6 glycans. (B) Glycan binding specificity of SC/09. (C) Glycan binding specificity of HA/226R.